Anteilseigner
Sichuan Kelun Pharm (20,43 %) UBS SDIC Fund Management Co., Ltd. (2,06 %) The Vanguard Group, Inc. (1,85 %) Dimensional Fund Advisors LP (0,78 %) Norges Bank Investment Management (0,75 %) BlackRock Fund Advisors (0,58 %) Fullgoal Fund Management Co., Ltd. (0,54 %) Wanjia Asset Management Co., Ltd. (0,43 %) Nordea Investment Management AB (Denmark) (0,42 %) Bosera Asset Management Co., Ltd. (0,35 %) BlackRock Advisors (UK) Ltd. (0,18 %) China Universal Asset Management Co., Ltd. (0,18 %) Value Partners Ltd. (0,16 %) UBS Switzerland AG (Investment Management) (0,14 %) American Century Investment Management, Inc. (0,14 %) Principal Global Investors (Hong Kong) Ltd. (0,10 %) UBS Asset Management Switzerland AG (0,10 %)
Kontakt
LIJUN INTERNATIONAL PHARMACEUTICAL